Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Cayen

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeysM N Cayen, D R Hicks, E S Ferdinandi, et al.
Biochemical Pharmacology|January 26, 1996
Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6N Yumibe, K Huie, K J Chen, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administrationC Lin, C Korduba, M Affrime, et al.
Clinical Therapeutics|May 20, 1998
Disposition of 14C-eptifibatide after intravenous administration to healthy menK B Alton, T Kosoglou, S Baker, et al.
British Journal of Clinical Pharmacology|January 3, 2001
Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidineT Kosoglou, M Salfi, J M Lim, et al.
British Heart Journal|December 1, 1975
Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgeryD J Coltart, M N Cayen, E B Stinson, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1986
The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogsM N Cayen, R Gonzalez, E S Ferdinandi, et al.
Biopharmaceutics & Drug Disposition|July 1, 1990
Species differences in the pharmacokinetics of recainam, a new anti-arrhythmic drugJ A Scatina, H B Kimmel, V Weinstein, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1986
Disposition and biotransformation of 14C-etodolac in manE S Ferdinandi, S N Sehgal, C A Demerson, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluationsM D Brannan, P Reidenberg, E Radwanski, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeysM N Cayen, D R Hicks, E S Ferdinandi, et al.
Biochemical Pharmacology|January 26, 1996
Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6N Yumibe, K Huie, K J Chen, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administrationC Lin, C Korduba, M Affrime, et al.
Clinical Therapeutics|May 20, 1998
Disposition of 14C-eptifibatide after intravenous administration to healthy menK B Alton, T Kosoglou, S Baker, et al.
British Journal of Clinical Pharmacology|January 3, 2001
Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidineT Kosoglou, M Salfi, J M Lim, et al.
British Heart Journal|December 1, 1975
Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgeryD J Coltart, M N Cayen, E B Stinson, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1986
The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogsM N Cayen, R Gonzalez, E S Ferdinandi, et al.
Biopharmaceutics & Drug Disposition|July 1, 1990
Species differences in the pharmacokinetics of recainam, a new anti-arrhythmic drugJ A Scatina, H B Kimmel, V Weinstein, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1986
Disposition and biotransformation of 14C-etodolac in manE S Ferdinandi, S N Sehgal, C A Demerson, et al.
Clinical Pharmacology and Therapeutics|September 1, 1995
Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluationsM D Brannan, P Reidenberg, E Radwanski, et al.
Pageof 6